Sun Pharmaceuticals Q2 PAT may dip 62.3% YoY to Rs. 848.7 cr: Kotak

Net Sales are expected to decrease by 15.2 percent Y-o-Y (up 12.8 percent Q-o-Q) to Rs. 7006.1 crore, according to Kotak.